Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
China · Delayed Price · Currency is CNY 25.61
+0.06 (0.23%)
At close: Feb 6, 2026
SHA:600332 Market Cap
SHA:600332 has a market cap or net worth of 39.78 billion as of February 6, 2026. Its market cap has decreased by -2.82% in one year.
Market Cap
39.78B
Enterprise Value
39.62B
Revenue
77.54B
Ranking
n/a
PE Ratio
13.94
Stock Price
25.61
Market Cap Chart
Since February 6, 2001, SHA:600332's market cap has increased from 3.73B to 39.78B, an increase of 966.97%. That is a compound annual growth rate of 9.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 39.78B | 0.22% |
| Dec 31, 2025 | 39.69B | -9.21% |
| Dec 31, 2024 | 43.72B | -1.87% |
| Dec 29, 2023 | 44.55B | -3.89% |
| Dec 30, 2022 | 46.36B | -11.03% |
| Dec 31, 2021 | 52.10B | 16.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Pharmaceuticals Holding | 57.78B |
| Jointown Pharmaceutical Group | 26.03B |
| China National Medicines Corporation | 21.98B |
| Liaoning Cheng Da | 18.34B |
| China Meheco Group | 16.13B |
| China National Accord Medicines Corporation | 13.72B |
| Qingdao Baheal Medical INC. | 12.58B |
| C.Q. Pharmaceutical Holding | 10.37B |